Abstract
Barriers to Enrollment in Clinical Trials in Patients with Aggressive B-Cell Non-Hodgkin Lymphoma That Progressed after Anti-CD19 CART Cell Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have